BEIJING: Recent studies from Thailand, Indonesia and Chile have affirmed the efficacy of a Covid-19 vaccine produced by China’s Sinovac Biotech.
A new study conducted by Thailand’s Chulalongkorn University showed that 99.49% of Thai recipients of the vaccine, known as CoronaVac, had developed antibody responses four weeks after their second shots, the Bangkok Post reported.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
